Latest Breaking News On - Baisong mei - Page 1 : vimarsana.com

Evercore ISI Trims Editas Medicine (NASDAQ:EDIT) Target Price to $7 00

Evercore ISI Trims Editas Medicine (NASDAQ:EDIT) Target Price to $7 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesJessica hopfieldBaisong meiEditas medicine incLos angeles capital managementCharles schwab investment management incMorgan stanleyInternational assets investment managementDimensional fund advisorsJpmorgan chase coVanguard group incEditas medicineGet free reportDirector jessica hopfieldFund advisors

Editas Medicine, Inc (NASDAQ:EDIT) Receives $13 90 Average Price Target from Analysts

Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year […]

Baisong meiJessica hopfieldJpmorgan chase coInternational assets investment managementCapital management incChina universal asset management coMorgan stanleyCitigroup incSecurities exchange commissionVanguard group incEditas medicine company profileEditas medicine incEditas medicineGet free reportExchange commissionDirector jessica hopfield

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHaydar frangoulHall velasquezCristi barnettRabi hannaBaisong meiEuropean hematology associationHarvard university casExchange commissionEditas medicine incEuropean hematology association congressDepartment of pediatric hematology oncologyBroad instituteBroad institute casPresent clinical data

Editas Medicine (NASDAQ:EDIT) PT Lowered to $9 00 at Barclays

Editas Medicine (NASDAQ:EDIT) PT Lowered to $9 00 at Barclays
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United kingdomGilmore neil oneillBaisong meiSwiss national bankJpmorgan chase coMorgan stanleySecurities exchange commissionEditas medicine incCommonwealth equity servicesCambridge investment research advisors incEditas medicineFree reportGet free reportExchange commissionNeilo neillNational bank

Editas Medicine (NASDAQ:EDIT) Lifted to Equal Weight at Morgan Stanley

Editas Medicine (NASDAQ:EDIT) Lifted to Equal Weight at Morgan Stanley
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United kingdomBaisong meiGilmore neil oneillMorgan stanleyEditas medicine incCommonwealth equity servicesSg americas securitiesYork mellon corpRaymond james associatesCambridge investment research advisors incJpmorgan chase coSecurities exchange commissionEditas medicineFree reportGet free reportExchange commission